Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00101283 · BASELINE

Baseline characteristics

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma · Source last updated 2023-07-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      16
    2. group Id
      BG001
      value
      13
    3. group Id
      BG002
      value
      29
    units
    Participants
groups
  1. description
    Pemetrexed disodium 500 mg/m2 IV over 10 minutes and carboplatin to AUC 5 IV over 30 minutes on day 1 of a 21-day cycle.
    id
    BG000
    title
    Pemetrexed/Carboplatin
  2. description
    Pemetrexed disodium 500 mg/m2 IV over 10 minutes on day 1 and gemcitabine 1000 mg/m2 IV over 30 minutes on days 1 and 8 of a 21-day cycle.
    id
    BG001
    title
    Pemetrexed/Gemcitabine
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          55
          upper Limit
          78
          value
          72
        2. group Id
          BG001
          lower Limit
          53
          upper Limit
          80
          value
          68
        3. group Id
          BG002
          lower Limit
          53
          upper Limit
          80
          value
          71
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          2
        2. group Id
          BG001
          value
          12
        3. group Id
          BG002
          value
          14
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          14
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          15
        title
        Male
    description
    Gender of participants who began treatment.
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      16
    2. group Id
      BG001
      value
      13
    3. group Id
      BG002
      value
      29
    units
    Participants
groups
  1. description
    Pemetrexed disodium 500 mg/m2 IV over 10 minutes and carboplatin to AUC 5 IV over 30 minutes on day 1 of a 21-day cycle.
    id
    BG000
    title
    Pemetrexed/Carboplatin
  2. description
    Pemetrexed disodium 500 mg/m2 IV over 10 minutes on day 1 and gemcitabine 1000 mg/m2 IV over 30 minutes on days 1 and 8 of a 21-day cycle.
    id
    BG001
    title
    Pemetrexed/Gemcitabine
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          55
          upper Limit
          78
          value
          72
        2. group Id
          BG001
          lower Limit
          53
          upper Limit
          80
          value
          68
        3. group Id
          BG002
          lower Limit
          53
          upper Limit
          80
          value
          71
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          2
        2. group Id
          BG001
          value
          12
        3. group Id
          BG002
          value
          14
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          14
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          15
        title
        Male
    description
    Gender of participants who began treatment.
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice